Lifestyle-Associated Cancer Epidemiology Market is expected to reach USD 13.12 billion by 2031

Lifestyle-Associated Cancer Epidemiology Market Trends & Forecast

According to a research study published by Knowledge Sourcing Intelligence (KSI), the lifestyle-associated cancer epidemiology market will expand from USD 8.96 billion in 2026 to USD 13.12 billion in 2031 at a CAGR of 7.9% during the forecast period.

Lifestyle-Associated Cancer Epidemiology revolves around the study and surveillance of cancers linked to modifiable behavioral and environmental risk factors, which are essential for providing public health systems, policymakers, and researchers with data to identify trends, assess burdens, and, as a result, design effective prevention and early intervention strategies. The key ideas which are focused upon include tracking incidents related to obesity, alcohol, tobacco, dietary patterns, as well as physical inactivity across several cancer types such as breast cancer, lung cancer, liver cancer, and others. In this particular space, technological approaches consist of advanced cancer registries as well as population-level behavioral surveillance with AI-driven predictive modeling and genomic integration for risk stratification.

Furthermore, several global efforts, including the World Health Organization's frameworks for non-communicable disease prevention and National Cancer Control programs, are playing an efficient role in the continuation of driving investments in epidemiological capacity. Not only this, but rising urbanization, incidentally, lifestyles, and dietary shifts are also amplifying the need for scalable surveillance systems.

Request a free sample copy or view the report summary: Lifestyle-Associated Cancer Epidemiology Market Report

Lifestyle-Associated Cancer Epidemiology Market Report Highlights

• WHO and partners strengthened global tobacco control and obesity prevention frameworks in 2025 as part of broader non-communicable disease initiatives.

• National Cancer Institute expanded funding for behavioral oncology and lifestyle-associated cancer epidemiology research programs in early 2026.

• CDC enhanced integration of behavioral risk factor surveillance with cancer registry data across multiple states and conditions.

• IARC advanced carcinogen classification and population-level risk assessment for lifestyle factors in ongoing 2025-2026 initiatives

Lifestyle-Associated Cancer Epidemiology Market Growth Drivers and Restraints

Growth Drivers:

• The Rising prevalence of key factors such as tobacco use, obesity, and alcohol consumption is regarded as primary drivers which are playing an important role in the increasing demand for detailed epidemiological tracking and prevention-focused data. Obesity is regarded as the core issue that influences inflammatory and hormonal pathways that are linked to multiple cancers, whereas tobacco use remains one of the leading causes of lung cancer. In this regard, public health campaigns and regulatory efforts are boosting the need for surveillance.

• The expansion of cancer registries, AI analytics and digital epidemiology platforms is supporting the real-time monitoring and predictive modeling for these cancer types. A governmental research organization is investing in harmonized datasets, a precision prevention program integrating behavioral and genomic risks, and policy-driven initiatives that could be essential in reducing the cancer burden. Furthermore, one of the major growth drivers revolves around the national and international emphasis on preventive healthcare, which includes screening programs and behavioral interventions.

Restraints:

• Uneven or fragmented cancer registry infrastructure, followed by the inconsistency of data quality across multiple regions, with limited screening participation, is hindering the comprehensive surveillance of cancer types. Additionally, the low adherence to behavioral interventions and challenges to equitable access are also preventing resources, resulting in constrained outcomes.

Lifestyle-Associated Cancer Epidemiology Market Growth Key Development

• April 2026: Union for International Cancer Control expanded international collaboration initiatives supporting prevention-focused cancer control policies and epidemiological data harmonisation.

• February 2026: The National Cancer Institute increased funding support for behavioural oncology and lifestyle-associated cancer epidemiology research programs.

• June 2025: The World Health Organisation expanded its global tobacco cessation framework under international non-communicable disease prevention initiatives to reduce the smoking-associated cancer burden.

Lifestyle-Associated Cancer Epidemiology Market Growth Segmentation

Knowledge Sourcing Intelligence has segmented the Lifestyle-Associated Cancer Epidemiology Market Growth based on cancer type, risk factor, age group, by healthcare setting, and region:

Lifestyle-Associated Cancer Epidemiology Market By Cancer Type

• Lung Cancer

• Breast Cancer

• Colorectal Cancer

• Liver Cancer

• Pancreatic Cancer

• Skin Cancer

Lifestyle-Associated Cancer Epidemiology Market By Risk Factor

• Tobacco Use

• Alcohol Consumption

• Obesity

• Dietary Factors

• Physical Inactivity

Lifestyle-Associated Cancer Epidemiology Market By Age Group

• Pediatric

• Adult

• Geriatric

Lifestyle-Associated Cancer Epidemiology Market By Healthcare Setting

• Hospitals

• Cancer Centers

• Preventive Care Clinics

Lifestyle-Associated Cancer Epidemiology Market By Region

• North America

  • USA

  • Canada

  • Mexico

• Europe

  • United Kingdom

  • Germany

  • France

  • Italy

  • Spain

  • Others

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • Thailand

  • Others

• South America

  • Brazil

  • Argentina

  • Others

• Middle East and Africa (MEA)

  • Saudi Arabia

  • UAE

  • Others

Lifestyle-Associated Cancer Epidemiology Market Key Players

• World Health Organization

• International Agency for Research on Cancer

• American Cancer Society

• National Cancer Institute

• Centers for Disease Control and Prevention

• Cancer Research UK

• Union for International Cancer Control

• Globocon